Awa, Stewie B.
HRN: 20-92-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
AMPICILLIN 500MG (VIAL)
08/14/2022
08/20/2022
IV
215mg
Q6hrs
Age With Mod Dhn; Urti
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes